Neo-ligands for innate immune receptors and the etiology of sterile inflammatory disease

Immunological Reviews

Volumn 220, Issue 1, 2007, Pages 113-128

  Beutler, Bruce ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Autoimmunity; Inflammation; Mutation; Proteome; Self reactivity; Toll like receptors

Indexed keywords

PROTEOME; TOLL LIKE RECEPTOR;

ANTIGEN RECOGNITION; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GERMPLASM; HERITABILITY; HUMAN; INFLAMMATION; INNATE IMMUNITY; LYMPHOCYTE; MOLECULAR CLONING; NEOPLASM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; SOMATIC CELL;

HUMANS; IMMUNITY, NATURAL; INFLAMMATION; LIGANDS; LINKAGE (GENETICS); MUTATION; PROTEINS; PROTEOME; RECEPTORS, IMMUNOLOGIC; TOLL-LIKE RECEPTORS;

EID: 35748950109     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.2007.00577.x     Document Type: Review

References (112)

1. Beutler B, et al. Genetic analysis of host resistance: toll-like receptor signaling and immunity at large. Annu Rev Immunol 2006 24 : 353 389.
2. Kawai T, Akira S. Innate immune recognition of viral infection. Nat Immunol 2006 7 : 131 137.
3. Ting JP, Kastner DL, Hoffman HM. CATERPILLERs, pyrin and hereditary immunological disorders. Nat Rev Immunol 2006 6 : 183 195.
4. Morens DM, Folkers GK, Fauci AS. The challenge of emerging and re-emerging infectious diseases. Nature 2004 430 : 242 249.
5. Beutler B, Rietschel ET. Timeline: innate immune sensing and its roots: the story of endotoxin 1. Nat Rev Immunol 2003 3 : 169 176.
6. Heppner G, Weiss DW. High susceptibility of strain A mice to endotoxin and endotoxin-red blood cell mixtures. J Bacteriol 1965 90 : 696 703.
7. O'Brien AD, Rosenstreich DL, Scher I, Campbell GH, MacDermott RP, Formal SB. Genetic control of susceptibility to Salmonella typhimurium in mice: role of the LPS gene. J Immunol 1980 124 : 20 24.
8. Rosenstreich DL, Weinblatt AC, O'Brien AD. Genetic control of resistance to infection in mice. CRC Crit Rev Immunol 1982 3 : 263 330.
9. Hagberg L, Hull R, Hull S, McGhee JR, Michalek SM, Svanborg Eden C. Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice. Infect Immun 1984 46 : 839 844.
10. Poltorak A, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998 282 : 2085 2088.
11. Hoebe K, et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signaling. Nature 2003 424 : 743 748.
12. Beutler B, Mahoney J, Le Trang N, Pekala P, Cerami A. Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells. J Exp Med 1985 161 : 984 995.
13. Beutler B, et al. Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature 1985 316 : 552 554.
14. Beutler B, Milsark IW, Cerami A. Passive immunization against cachectin/tumor necrosis factor (TNF) protects mice from the lethal effect of endotoxin. Science 1985 229 : 869 871.
15. Car BD, et al. Interferon gamma receptor deficient mice are resistant to endotoxic shock. J Exp Med 1994 179 : 1437 1444.
16. Ozmen L, et al. Interleukin 12, interferon gamma, and tumor necrosis factor a are the key cytokines of the generalized Shwartzman reaction. J Exp Med 1994 180 : 907 915.
17. Wysocka M, et al. Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice. Eur J Immunol 1995 25 : 672 676.
18. Karaghiosoff M, et al. Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock. Nat Immunol 2003 4 : 471 477.
19. Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 2002 416 : 603 607.
20. Viglianti GA, Lau CM, Hanley TM, Miko BA, Shlomchik MJ, Marshak-Rothstein A. Activation of autoreactive B cells by CpG dsDNA. Immunity 2003 19 : 837 847.
21. Engelmann H, et al. Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity. J Biol Chem 1990 265 : 14497 14504.
22. Sultzer BM. Genetic control of leucocyte responses to endotoxin. Nature 1968 219 : 1253 1254.
23. Watson J, Riblet R. Genetic control of responses to bacterial lipopolysaccharides in mice. I. Evidence for a single gene that influences mitogenic and immunogenic respones to lipopolysaccharides. J Exp Med 1974 140 : 1147 1161.
24. Watson J, Riblet R. Genetic control of responses to bacterial lipopolysaccharides in mice. II. A gene that influences a membrane component involved in the activation of bone marrow-derived lymphocytes by lipipolysaccharides. J Immunol 1975 114 : 1462 1468.
25. Watson J, Riblet R, Taylor BA. The response of recombinant inbred strains of mice to bacterial lipopolysaccharides. J Immunol 1977 118 : 2088 2093.
26. Rietschel ET, et al. The chemical structure of bacterial endotoxin in relation to bioactivity. Immunobiology 1993 187 : 169 190.
27. Takayama K, Qureshi N, Beutler B, Kirkland TN. Diphosphoryl lipid A from Rhodopseudomonas spaeroides ATCC 17023 blocks induction of cachectin in macrophages by lipopolysaccharide. Infec Immun 1989 57 : 1336 1338.
28. Ohto U, Fukase K, Miyake K, Satow Y. Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa. Science 2007 316 : 1632 1634.
29. Georgel P, et al. Vesicular stomatitis virus glycoprotein G activates a specific antiviral Toll-like receptor 4-dependent pathway. Virology 2007 362 : 304 313.
30. Jude BA, et al. Subversion of the innate immune system by a retrovirus. Nat Immunol 2003 4 : 573 578.
31. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS-binding protein. Science 1990 249 : 1431 1433.
32. Jiang Z, et al. CD14 is required for MyD88-independent LPS signaling. Nat Immunol 2005 6 : 565 570.
33. Malakhova O, Malakhov M, Hetherington C, Zhang DE. Lipopolysaccharide activates the expression of ISG15-specific protease UBP43 via interferon regulatory factor 3. J Biol Chem 2002 277 : 14703 14711.
34. Doyle S, et al. IRF3 mediates a TLR3/TLR4-dpecific antiviral gene program. Immunity 2002 17 : 251.
35. Berczi I, Bertok L, Bereznai T. Comparative studies on the toxicity of Escherichia coli lipopolysaccharide endotoxin in various animal species. Can J Microbiol 1966 12 : 1070 1071.
36. Schneider DS, Hudson KL, Lin TY, Anderson KV. Dominant and recessive mutations define functional domains of Toll, a transmembrane protein required for dorsal-ventral polarity in the Drosophila embryo. Genes Dev 1991 5 : 797 807.
37. Ding AH, Porteu F, Sanchez E, Nathan CF. Shared actions of endotoxin and taxol on TNF receptors and TNF release. Science 1990 248 : 370 372.
38. Hemmi H, et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 2002 3 : 196 200.
39. Smirnova I, Hamblin M, McBride C, Beutler B, Di Rienzo A. Excess of rare amino acid polymorphisms in the Toll-like receptor 4 in humans. Genetics 2001 158 : 1657 1664.
40. Ohta T. Role of diversifying selection and gene conversion in evolution of major histocompatibility complex loci. Proc Natl Acad Sci USA 1991 88 : 6716 6720.
41. Gyllensten U, Bergstrom T, Josefsson A, Sundvall M, Erlich HA. Rapid allelic diversification and intensified selection at antigen recognition sites of the MHC class II DPB1 locus during hominoid evolution. Tissue Antigens 1996 47 : 212 221.
42. Apanius V, Penn D, Slev PR, Ruff LR, Potts WK. The nature of selection on the major histocompatibility complex. Crit Rev Immunol 1997 17 : 179 224.
43. Kim S, et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 2005 436 : 709 713.
44. Wu MF, Raulet DH. Class I-deficient hemopoietic cells and nonhemopoietic cells dominantly induce unresponsiveness of natural killer cells to class I-deficient bone marrow cell grafts. J Immunol 1997 158 : 1628 1633.
45. Raulet DH, Vance RE. Self-tolerance of natural killer cells. Nat Rev Immunol 2006 6 : 520 531.
46. Raulet DH. Missing self recognition and self tolerance of natural killer (NK) cells. Semin Immunol 2006 18 : 145 150.
47. Beeson PB. Tolerance to bacterial pyrogens: I. Factors influencing its development. J Exp Med 1947 86 : 29 38.
48. Beeson PB. Tolerance of bacterial pyrogens. II. Role of the reticulo-endothelial system. J Exp Med 1947 86 : 39 44.
49. Foster SL, Hargreaves DC, Medzhitov R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 2007 447 : 972 978.
50. bi-Rached L, Parham P. Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues. J Exp Med 2005 201 : 1319 1332.
51. Sambrook JG, et al. Single haplotype analysis demonstrates rapid evolution of the killer immunoglobulin-like receptor (KIR) loci in primates. Genome Res 2005 15 : 25 35.
52. Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 2002 20 : 217 251.
53. Khakoo SI, et al. Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans. Immunity 2000 12 : 687 698.
54. Valiante NM, Lienert K, Shilling HG, Smits BJ, Parham P. Killer cell receptors: keeping pace with MHC class I evolution. Immunol Rev 1997 155 : 155 164.
55. Bell JK, et al. The molecular structure of the Toll-like receptor 3 ligand-binding domain. Proc Natl Acad Sci USA 2005 102 : 10976 10980.
56. Choe J, Kelker MS, Wilson IA. Crystal structure of human Toll-like receptor 3 (TLR3) ectodomain. Science 2005 309 : 581 585.
57. Kobe B, Deisenhofer J. A structural basis of the interactions between leucine-rich repeats and protein ligands. Nature 1995 374 : 183 186.
58. Kobe B, Deisenhofer J. Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats. Nature 1993 366 : 751 756.
59. Andersen-Nissen E, Smith KD, Bonneau R, Strong RK, Aderem A. A conserved surface on Toll-like receptor 5 recognizes bacterial flagellin. J Exp Med 2007 204 : 393 403.
60. Yarovinsky F, et al. TLR11 activation of dendritic cells by a protozoan profilin-like orotein. Science 2005 308 : 1626 1629.
61. Pancer Z, Amemiya CT, Ehrhardt GR, Ceitlin J, Gartland GL, Cooper MD. Somatic diversification of variable lymphocyte receptors in the agnathan sea lamprey. Nature 2004 430 : 174 180.
62. Takeuchi O, et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999 11 : 443 451.
63. Poltorak A, Ricciardi-Castagnoli P, Citterio A, Beutler B. Physical contact between LPS and Tlr4 revealed by genetic complementation. Proc Natl Acad Sci USA 2000 97 : 2163 2167.
64. Lien E, et al. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest 2000 105 : 497 504.
65. Shimazu R, et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 1999 189 : 1777 1782.
66. Nagai Y, et al. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol 2002 3 : 667 672.
67. Akashi S, et al. Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition. Int Immunol 2001 13 : 1595 1599.
68. Kurt-Jones EA, et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 2000 1 : 398 401.
69. Huber M, et al. R-form LPS, the master key to the activation of TLR4/MD-2-positive cells. Eur J Immunol 2006 36 : 701 711.
70. Taylor KR, et al. Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on TLR4, CD44 and MD-2. J Biol Chem 2007 282 : 18265 18275.
71. Ogata H, et al. The toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells. J Exp Med 2000 192 : 23 30.
72. Ozinsky A, et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci USA 2000 97 : 13766 13771.
73. Chuang T, Ulevitch RJ. Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. Biochim Biophys Acta 2001 1518 : 157 161.
74. Hoebe K, et al. CD36 is a sensor of diacylglycerides. Nature 2005 433 : 523 527.
75. Bauer S, et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci USA 2001 98 : 9237 9242.
76. Tabeta K, et al. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat Immunol 2006 7 : 156 164.
77. Brinkmann MM, Spooner E, Hoebe K, Beutler B, Ploegh HL, Kim YM. The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling. J Cell Biol 2007 177 : 265 275.
78. Yoneyama M, et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004 5 : 730 737.
79. Kato H, et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity 2005 23 : 19 28.
80. Gagnon E, et al. Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages. Cell 2002 110 : 119 131.
81. Kawai T, et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 2005 6 : 981 988.
82. Yoneyama M, et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 2005 175 : 2851 2858.
83. Girardin SE, et al. Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 2003 300 : 1584 1587.
84. Girardin SE, et al. Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J Biol Chem 2003 278 : 41702 41708.
85. Girardin SE, et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003 278 : 8869 8872.
86. Gao JL, Lee EJ, Murphy PM. Impaired antibacterial host defense in mice lacking the N-formylpeptide receptor. J Exp Med 1999 189 : 657 662.
87. Martinon F, Tschopp J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 2004 117 : 561 574.
88. Tanabe T, et al. Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition. EMBO J 2004 23 : 1587 1597.
89. Kobayashi K, et al. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 2002 416 : 194 199.
90. Hugot JP, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001 411 : 599 603.
91. Miceli-Richard C, et al. CARD15 mutations in Blau syndrome. Nat Genet 2001 29 : 19 20.
92. Maeda S, et al. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1 beta processing. Science 2005 307 : 734 738.
93. Eckmann L, Karin M. NOD2 and Crohn's disease: loss or gain of function? Immunity 2005 22 : 661 667.
94. Ma Y, et al. Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis. J Cell Biol 2006 175 : 209 215.
95. Harju K, Glumoff V, Hallman M. Ontogeny of Toll-like receptors Tlr2 and Tlr4 in mice. Pediatr Res 2001 49 : 81 83.
96. Harju K, et al. Expression of toll-like receptor 4 and endotoxin responsiveness in mice during perinatal period. Pediatr Res 2005 57 : 644 648.
97. Holmlund U, et al. Expression and regulation of the pattern recognition receptors Toll-like receptor-2 and Toll-like receptor-4 in the human placenta. Immunology 2002 107 : 145 151.
98. Beutler B, Du X, Xia Y. Precis on forward genetics in mice. Nat Immunol 2007 8 : 659 664.
99. The Wellcome Trust Case Control Consortium. Genome-wide association study of 14 000 cases of seven common diseases and 3,000 shared controls. Nature 2007 447 : 661 678.
100. Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 2001 29 : 301 305.
101. John S, et al. Whole-genome scan, in a complex disease, using 11 245 single-nucleotide polymorphisms: comparison with microsatellites. Am J Hum Genet 2004 75 : 54 64.
102. Osorio YF, et al. Dense genome-wide linkage analysis of rheumatoid arthritis, including covariates. Arthritis Rheum 2004 50 : 2757 2765.
103. Tamiya G, et al. Whole genome association study of rheumatoid arthritis using 27 039 microsatellites. Hum Mol Genet 2005 14 : 2305 2321.
104. Nachman MW, Crowell SL. Estimate of the mutation rate per nucleotide in humans (in process citation). Genetics 2000 156 : 297 304.
105. Schroder M, Kaufman RJ. The mammalian unfolded protein response. Annu Rev Biochem 2005 74 : 739 789.
106. Razonable RR, et al. Secretion of proinflammatory cytokines and chemokines during amphotericin B exposure is mediated by coactivation of toll-like receptors 1 and 2. Antimicrob Agents Chemother 2005 49 : 1617 1621.
107. Sau K, Mambula SS, Latz E, Henneke P, Golenbock DT, Levitz SM. The antifungal drug amphotericin B promotes inflammatory cytokine release by a Toll-like receptor- and CD14-dependent mechanism. J Biol Chem 2003 278 : 37561 37568.
108. Heil F, et al. The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily. Eur J Immunol 2003 33 : 2987 2997.
109. Rakoff-Nahoum S, Medzhitov R. Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 2007 317 : 124 127.
110. Lau CM, et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J Exp Med 2005 202 : 1171 1177.
111. Baccala R, Hoebe K, Kono DH, Beutler B, Theofilopoulos AN. TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nat Med 2007 13 : 543 551.
112. Nattermann J, Du X, Wei Y, Shevchenko D, Beutler B. Endotoxin-mimetic effect of antibodies against Toll-like receptor 4. J Endotoxin Res 2000 6 : 257 264.